Phillip Schwartz - Jan 20, 2022 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
Stock symbol
ENTX
Transactions as of
Jan 20, 2022
Transactions value $
$25,250
Form type
4
Date filed
1/24/2022, 03:17 PM
Previous filing
Jan 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTX Ordinary Shares, par value NIS 0.0000769 per share Purchase $25.3K +10K +1.67% $2.53 607K Jan 20, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.49 to $2.56, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.